No Photo Available

Last Update

2016-11-23T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Michael Riebe?

Dr. Michael T. Riebe PhD

Senior Vice President Pharmaceutical Development and Research

Pearl Therapeutics , Inc.

Direct Phone: (919) ***-****       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Pearl Therapeutics , Inc.

200 CARDINAL WAY

Redwood City, California 94063

United States

Company Description

Pearl Therapeutics is a privately held company developing combination therapies for the treatment of highly prevalent respiratory diseases, including chronic obstructive pulmonary disease and asthma. Pearl is rapidly advancing a pipeline of products inclu ... more

Find other employees at this company (255)

Background Information

Employment History

Vice President of Research and Development

iCeutica Inc

Senior Director

Merck & Co. , Inc.

Director

RTI International

Position, Respiratory Product Development

GlaxoSmithKline plc

Director

Glaxo Wellcome Inc.

Education

B.A. degree

chemistry

Kalamazoo College

Ph.D.

Web References (17 Total References)


News 2013 Archives - nlvpartners

www.nlvpartners.com [cached]

Pearl Therapeutics Strengthens Its Organization by Hiring Dr. Michael Riebe, an Industry Veteran in Respiratory Product Development REDWOOD CITY, CALIF., January 17, 2013 - Pearl Therapeutics Inc. today announced that Michael Riebe, Ph.D. has joined Pearl...


Pearl Therapeutics hires ...

www.oindpnews.com [cached]

Pearl Therapeutics hires Michael Riebe | Pearl Therapeutics hires Michael Riebe | . . . Read more

...
Pearl Therapeutics hires Michael Riebe | Pearl Therapeutics hires Michael Riebe | . . . Read more
...
Pearl Therapeutics hires Michael Riebe Jan 172013
Pearl Therapeutics, which is developing several inhaled drugs, has announced that it has hired Michael Riebe as VP, Pharmaceutical Development and Research, effective immediately. Riebe, a past chair and current steering committee member of the AAPS Inhalation and Nasal Technology Focus Group, was most recently VP of Research and Development at iCeutica and previously worked in inhaled drug development at Merck and at Glaxo.
...
Speaking for the management and board of directors, we welcome Mike to the Pearl team."


NewMexicoLifeScience.com

www.newmexicolifescience.com [cached]

Pearl Therapeutics appoints Dr. Michael Riebe VP as pharmaceutical development & research Pearl Therapeutics announced the appointment of Michael Riebe, Ph.D. as VP, pharmaceutical development and research. Prior to joining Pearl Therapeutics, Dr. Riebe was VP of R&D at iCeutica where he led development of the Company's pipeline of pain, oncology and respiratory products.


New Leaf Venture Partners :: a leader in healthcare technology venture investing

www.nlvpartners.com [cached]

REDWOOD CITY, CALIF., January 17, 2013 - Pearl Therapeutics Inc. today announced that Michael Riebe, Ph.D. has joined Pearl Therapeutics as vice president, pharmaceutical development and research, effective immediately.

...
Speaking for the management and board of directors, we welcome Mike to the Pearl team."
Prior to joining Pearl Therapeutics, Dr. Riebe was vice president of research and development at iCeutica where he led development of the Company's pipeline of pain, oncology and respiratory products. Prior to iCeutica, Dr. Riebe held various roles at Merck, most recently senior scientific director in respiratory product development; and at RTI, an independent, nonprofit research and development organization. From 1990 through 2003, Dr. Riebe held several positions in respiratory product development at GlaxoSmithKline and its predecessor, Glaxo Wellcome, where he led project teams responsible for pharmaceutical development of Serevent®, Ventolin® HFA, and Seretide®/Advair® HFA. Dr. Riebe received his B.A. degree in chemistry from Kalamazoo College and his Ph.D. in analytical chemistry from the University of Wisconsin - Madison. He has served in numerous leadership positions within the American Chemical Society and the American Association for Pharmaceutical Scientists, including as chairman of the AAPS Inhalation and Nasal Technology Focus Group.


News » OINDPnews » Page 3

www.oindpnews.com [cached]

Pearl Therapeutics hires Michael Riebe Jan 172013

Pearl Therapeutics, which is developing several inhaled drugs, has announced that it has hired Michael Riebe as VP, Pharmaceutical Development and Research, effective immediately. Riebe, a past chair and current steering committee member of the AAPS Inhalation and Nasal Technology Focus Group, was most recently VP of Research and Development at iCeutica and previously worked . . . Read more

Similar Profiles

Other People with this Name

Other people with the name Riebe

Lori Riebe
First Commercial Bank, N.A.

Susan Riebe
Kinder Morgan , Inc.

Vanessa Riebe
Graebel Companies Inc

Catherine Riebe
Rose International Inc

Mark Riebe
Texas Bank Financial

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory